RxSight Inc (NAS:RXST)

Q2 2025 Rxsight Inc Earnings Call Transcript

Aug 7, 2025 / 08:30 PM GMT

Release Date Price: $7.79 (+3.18%)

Transcript 10-Q8-K

Key Points

Positve

RxSight Inc (RXST) has unified its LAL sales and clinical support personnel into a single customer success organization to enhance customer experience and drive growth.
The company has expanded its engagement with surgeons, optometrists, and clinical staff through peer-to-peer programs to support the mastery of postoperative vision optimization.
RxSight Inc (RXST) reported a gross margin of 74.9% in Q2 2025, an increase from 69.5% in the same period last year, reflecting a favorable shift in product mix.
The company has a strong balance sheet with cash equivalents and short-term investments totaling $227.5 million as of June 30, 2025.
RxSight Inc (RXST) is focusing on global expansion with regulatory approvals in key European and Asian markets, opening new growth opportunities.

Negative

Q2 2025 revenue decreased by 4% compared to the same quarter last year, and by 11% compared to Q1 2025, indicating a decline in sales performance.
LDD sales have significantly decreased, with a 49% drop in units sold compared to the prior period, impacting overall revenue.
The company reported a GAAP net loss of $11.8 million in Q2 2025, a larger loss compared to $6.1 million in the same quarter of 2024.
Operating expenses have increased, with SGNA expenses rising by 19% year-over-year, primarily due to higher personnel costs and stock-based compensation.
The company anticipates a slower second half of 2025 due to continued softness in LAL adoption and fewer expected new LDD sales, impacting revenue guidance.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RXST.OQ - Rxsight Inc
Q2 2025 Rxsight Inc Earnings Call
Aug 07, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for standing by. My name is Desiree and I will be your conference operator today. At this time, I would like to welcome everyone to the RXI 2nd quarter 2025 earnings conference call. All lines have been placed on mute to prevent any background noise.

After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star, followed by the number one in your telephone keypad. If you would like to withdraw your question again.

Press the star one. I would not like to turn the conference over to Oliver Mavchevich, Vice President of Investor relations. You may begin.

------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.